Ciuleanu, T., Ahmed, S., Kim, J., Mezger, J., Park, K., Thomas, M., . . . Blackhall, F. (2017). Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung cancer. Br J Cancer.
Citação norma ChicagoCiuleanu, Tudor-Eliade, et al. "Randomised Phase 2 Study of Maintenance Linsitinib (OSI-906) in Combination With Erlotinib Compared With Placebo Plus Erlotinib After Platinum-based Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer." Br J Cancer 2017.
Citação norma MLACiuleanu, Tudor-Eliade, et al. "Randomised Phase 2 Study of Maintenance Linsitinib (OSI-906) in Combination With Erlotinib Compared With Placebo Plus Erlotinib After Platinum-based Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer." Br J Cancer 2017.